Patents - Clinical Trials Arena https://www.clinicaltrialsarena.com/patents/ Hard data and deep insights on clinical trials strategy & operations Mon, 04 Mar 2024 06:35:57 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Patents - Clinical Trials Arena https://www.clinicaltrialsarena.com/patents/ 32 32 Signal: US lays out plan to seize govt-funded drug patents to lower cost https://www.clinicaltrialsarena.com/news/us-lays-out-plan-to-seize-govt-funded-drug-patents-to-lower-cost/ Fri, 08 Dec 2023 17:17:17 +0000 https://www.clinicaltrialsarena.com/?p=193624 The newly announced plans would allow third parties to manufacture such drugs if manufacturers make them unaffordable.

The post Signal: US lays out plan to seize govt-funded drug patents to lower cost appeared first on Clinical Trials Arena.

]]> The post Signal: US lays out plan to seize govt-funded drug patents to lower cost appeared first on Clinical Trials Arena.

]]> Signal: Moderna mRNA patent revoked by EPO after Pfizer suit https://www.clinicaltrialsarena.com/news/moderna-mrna-patent-revoked-by-european-patent-office-after-pfizer-suit/ Wed, 22 Nov 2023 15:26:46 +0000 https://www.clinicaltrialsarena.com/?p=192491 Pfizer and BioNTech countersued Moderna following an initial August 2022 suit alleging that its patents were overly broad.

The post Signal: Moderna mRNA patent revoked by EPO after Pfizer suit appeared first on Clinical Trials Arena.

]]> The post Signal: Moderna mRNA patent revoked by EPO after Pfizer suit appeared first on Clinical Trials Arena.

]]> Signal: Mobility exoskeleton developer Wandercraft begins operations in US https://www.clinicaltrialsarena.com/news/signal-mobility-exoskeleton-developer-wandercraft-begins-operations-in-us/ Fri, 13 Oct 2023 12:17:21 +0000 https://www.clinicaltrialsarena.com/?p=189495 Wandercraft has launched its mobility exoskeleton Atalante X in the US in partnership with the Kessler Foundation.

The post Signal: Mobility exoskeleton developer Wandercraft begins operations in US appeared first on Clinical Trials Arena.

]]> The post Signal: Mobility exoskeleton developer Wandercraft begins operations in US appeared first on Clinical Trials Arena.

]]> Signal: Serum Institute of India plans to increase global reach https://www.clinicaltrialsarena.com/news/serum-institute-of-india-plans-to-increase-global-reach/ Fri, 06 Oct 2023 12:44:44 +0000 https://www.clinicaltrialsarena.com/uncategorized/serum-institute-of-india-plans-to-increase-global-reach/ Serum is already India's most valuable unlisted company, and it is looking to expand its offering into wealthier nations.

The post Signal: Serum Institute of India plans to increase global reach appeared first on Clinical Trials Arena.

]]> The post Signal: Serum Institute of India plans to increase global reach appeared first on Clinical Trials Arena.

]]> Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US https://www.clinicaltrialsarena.com/news/eli-lillys-176-5m-teva-patent-infringement-loss-overturned-in-us/ Wed, 27 Sep 2023 12:28:11 +0000 https://www.clinicaltrialsarena.com/news/eli-lillys-176-5m-teva-patent-infringement-loss-overturned-in-us/ A District Judge has overturned last year's jury verdict, declaring the application of Teva's patents too broad.

The post Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US appeared first on Clinical Trials Arena.

]]> The post Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US appeared first on Clinical Trials Arena.

]]> Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions https://www.clinicaltrialsarena.com/news/signal-porosome-files-comprehensive-patent/ Tue, 22 Aug 2023 10:47:18 +0000 https://www.clinicaltrialsarena.com/news/signal-porosome-files-comprehensive-patent/ The biopharma company has filed a comprehensive patent to address cystic fibrosis and other ailments.

The post Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions appeared first on Clinical Trials Arena.

]]> The post Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions appeared first on Clinical Trials Arena.

]]> Patent activity in the pharmaceutical industry decreased in Q3 2023 https://www.clinicaltrialsarena.com/data-insights/patent-activity-in-the-pharmaceutical-industry-decreased-in-q3-2023/ https://www.clinicaltrialsarena.com/data-insights/patent-activity-in-the-pharmaceutical-industry-decreased-in-q3-2023/#respond Wed, 09 Aug 2023 23:00:00 +0000

The post Patent activity in the pharmaceutical industry decreased in Q3 2023 appeared first on Clinical Trials Arena.

]]>

The post Patent activity in the pharmaceutical industry decreased in Q3 2023 appeared first on Clinical Trials Arena.

]]> https://www.clinicaltrialsarena.com/data-insights/patent-activity-in-the-pharmaceutical-industry-decreased-in-q3-2023/feed/ 0 Q4 2023 update: patent activity in the pharmaceutical industry https://www.clinicaltrialsarena.com/dashboards/patents/patent-activity-pharmaceutical-industry/ https://www.clinicaltrialsarena.com/dashboards/patents/patent-activity-pharmaceutical-industry/#respond Wed, 09 Aug 2023 23:00:00 +0000

The post Q4 2023 update: patent activity in the pharmaceutical industry appeared first on Clinical Trials Arena.

]]>

The post Q4 2023 update: patent activity in the pharmaceutical industry appeared first on Clinical Trials Arena.

]]> https://www.clinicaltrialsarena.com/dashboards/patents/patent-activity-pharmaceutical-industry/feed/ 0 Patents signal: Patent authorities in China champion grants awarded to Pharma companies https://www.clinicaltrialsarena.com/news/patents-signal-patent-authorities-in-china-top-others-in-grants/ Tue, 01 Aug 2023 08:30:00 +0000 Pharma companies were awarded more grants by patents authorities in China, delivering almost five times the grants in the US.

The post Patents signal: Patent authorities in China champion grants awarded to Pharma companies appeared first on Clinical Trials Arena.

]]> The post Patents signal: Patent authorities in China champion grants awarded to Pharma companies appeared first on Clinical Trials Arena.

]]> Patents signal: Chinese Academy of Sciences tops assignees for Q2 2023 https://www.clinicaltrialsarena.com/news/patents-signal-chinese-academy-of-sciences-tops-asignees-for-q2-2023/ Tue, 25 Jul 2023 09:36:06 +0000 https://www.clinicaltrialsarena.com/news/patents-signal-chinese-academy-of-sciences-tops-asignees-for-q2-2023/ Chinese Academy of Sciences took the lead in grants received over Q2 2023 with top therapy area being severe acute respiratory syndrome.

The post Patents signal: Chinese Academy of Sciences tops assignees for Q2 2023 appeared first on Clinical Trials Arena.

]]> The post Patents signal: Chinese Academy of Sciences tops assignees for Q2 2023 appeared first on Clinical Trials Arena.

]]>